Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
StemBanc is a biotechnology company specializing in the long-term cryogenic preservation of newborn stem cells derived from umbilical cord blood and cord tissue. The company provides families with a biological insurance service, storing these versatile cells for potential future use in treating a wide range of life-threatening diseases, including various cancers and blood disorders. StemBanc operates state-of-the-art laboratory facilities and utilizes advanced processing techniques to ensure the highest possible cell viability. By offering comprehensive collection, transport, and storage services, the company aims to make regenerative medicine resources accessible for personalized healthcare applications.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Stembanc.